Stromal-epithelial interactions play a central role in development and tumorigenesis. Bone morphogenetic protein (BMP) signaling in the intestine is involved in both of these processes. Inactivation of BMP pathway genes in the epithelium is known to cause intestinal polyposis. However, the role of the intestinal stroma in polyp initiation is incompletely understood. We observed that conditional inactivation of the BMP type II receptor (BMPRII) in the stroma leads to epithelial hyperplasia throughout the colon with increased epithelial cell proliferation. Mutant mice developed rectal bleeding and hamartomatous polyps in the colorectum. The polyps demonstrated increased proliferation of epithelial and mesenchymal cells in the mucosa with an expansion of the myofibroblast cell population. These results demonstrate that genetic mutations altering the BMP signaling pathway in the stromal microenvironment can lead to epithelial tumors in the colon.
Introduction
The intestinal epithelium is in a constant state of renewal with cells lost at the surface and continually replaced by cells rapidly proliferating in the crypts. Maintaining homeostasis in this self-renewing environment requires coordination of cell proliferation and cell death. Two of the principal components in this intestinal homeostasis are bone morphogenetic protein (BMP) and Wnt-b-catenin signaling. BMP activity inhibits cell proliferation and increases apoptosis in the intestinal epithelium (Haramis et al., 2004; Hardwick et al., 2004) , in part, by suppressing Wnt-b-catenin signaling (He et al., 2004) , a pathway which promotes epithelial cell proliferation (Pinto et al., 2003) . Mutations in either pathway lead to dysregulated growth and the formation of epithelial tumors (van den Brink, 2004) .
BMPs transduce their signals by binding to two different serine/threonine kinase receptors, type I (BMPRI) and type II (BMPRII), and activating downstream signaling molecules through Smad-dependent and Smad-independent pathways (Miyazono et al., 2005) . Germline mutations in BMPRIA and Smad4 have been identified in patients with juvenile polyposis, an autosomal-dominant condition characterized by gastrointestinal hamartomatous polyps and a predisposition for colorectal cancer (Howe et al., 1998 (Howe et al., , 2004 . Inhibition of BMP activity in mice via transgenic expression of noggin in the intestinal epithelium leads to formation of ectopic crypts and a histologic phenotype similar to human juvenile polyposis in both small and large intestine (Haramis et al., 2004; Batts et al., 2006) . Targeted inactivation of BMPRIA in epithelial cells results in similar findings (He et al., 2004) with expansion of the intestinal stem cell population and growth of polyps in the small intestine.
Studies of intestinal polyposis and neoplasia have traditionally focused on the role of genetic mutations in epithelial cells. The observed expansion of the stroma was thought to be a secondary event. However, the important role of the stromal microenvironment in the initiation and progression of epithelial cancers has until recently been under appreciated (Powell et al., 1999 (Powell et al., , 2005 Bhowmick et al., 2004b) . In juvenile polyposis, for example, genetic alterations have been identified in the stromal fibroblasts (Jacoby et al., 1997) . Mice with Smad4-deficient T cells were recently shown to develop epithelial cancers throughout the intestinal tract (Kim et al., 2006) . Inactivation of transforming growth factor-b (TGF-b) type II receptor in stromal fibroblasts leads to epithelial cancers in the prostate and stomach of mice (Bhowmick et al., 2004a) . Mammary fibroblasts overexpressing hepatocyte growth factor (HGF) or TGF-b1 induce epithelial carcinomas of the breast (Kuperwasser et al., 2004) . These results suggest that the stromal environment can initiate tumorigenesis in the overlying epithelium.
Given the tumor-suppressive role of BMP signaling in the genesis of intestinal polyps and the importance of the stroma in induction of epithelial tumors in other tissues, we sought to determine the role of stromal BMP signaling in the gut. Conditional inactivation of BMPRII was achieved using the nestin-Cre transgene in the stroma of the colorectal mucosa, and in patches of epithelial cells and smooth muscle. Mutant mice developed intestinal bleeding, epithelial hyperplasia and multiple hamartomatous polyps in the colorectum. These polyps displayed Cre recombinase activity in the mesenchymal cells of the mucosa, but not in the colonic epithelium, supporting a central role for the stromal environment in the initiation of intestinal polyps.
Results

Nestin-Cre induces recombination in the colon
To determine the intestinal cell types expressing Cre recombinase in mice carrying the nestin-Cre transgene, nestin-Cre mice were mated with mice carrying the ROSA26 reporter transgene. Intestinal cells in which the transgene underwent Cre-mediated recombination were detected using b-galactosidase histochemistry. bGalactosidase activity was detected in small clusters of epithelial cells in the colon (Figures 1a and b) . bGalactosidase activity was also present in the smooth muscle layers (Figures 1c and d) , enteric ganglia (Figure 1d, arrowhead) , and stromal cells of the mucosa (Figure 1d, arrow) . A similar pattern of b-galactosidase activity was observed in the small intestine, except that epithelial staining was not detected. 
Mutant mice exhibit pan-colonic epithelial overgrowth
In contrast to the normal colonic wall of control mice (Figures 2d and 3a) , mutant mice had a grossly thickened mucosa along the length of the colorectum (Figures 2e and 3b ). Histologic evaluation of the mutant colonic mucosa revealed epithelial hyperplasia along the entire colorectum. Alcian blue staining was used as a marker of mucin production from goblet cells. Marked expansion of the goblet cell population was observed in the mutant colon (Figures 3d and e). Sections were stained with an antibody against proliferating cell nuclear antigen (PCNA), a marker of cell proliferation. In control colons, PCNA-immunoreactive epithelial cells were predominantly limited to the base of normal crypts (Figure 3g ), while mutant colon demonstrated expansion of the proliferative compartment ( Figure 3h ). Terminal deoxynucleotidyl transferasemediated dUTP nick end-labeling (TUNEL) staining revealed that there was no significant difference in the number of apoptotic cells in control colon (Figure 3j ) and the hyperplastic epithelium of the mutant (Figure 3k ). In unevenly distributed crypts, mildly enlarged nuclei with disarray and limited stratification were noted (data not shown). The features observed in mutant mice are consistent with hamartomatous polyps of the colon (Wirtzfeld et al., 2001) . No polyps were detected in the small intestine.
BMPRII inactivation in the stroma leads to polyp formation To determine whether or not Cre recombinase was expressed in the polyps, b-galactosidase activity was measured in the colons of mutant mice, which also carried the R26R transgene. b-Galactosidase activity was not detected on the epithelial surface of the tumor (Figure 4d, arrowhead) , but was present in patches of surrounding epithelium (Figure 4d, arrow) . Crosssections of the polyps were stained for b-galactosidase activity ( Figure 4e ) and immunoreactivity ( Figure 4f ) and revealed Cre recombinase activity in the stroma, but not in the epithelial cells.
Loss of stromal BMPRII signaling promotes proliferation and inhibits apoptosis in the polyp epithelium Sections of colonic polyps from mutant mice demonstrated marked expansion of proliferative epithelial cells, with PCNA immunoreactivity extending into the upper half of the crypts (Figure 3i ). Unlike control littermates, a proliferative population of mesenchymal cells was also observed in the polyp (Figure 3i , arrow). Cell apoptosis was markedly diminished in the surface epithelium of the polyps (Figure 3l ) compared to control epithelium ( Figure 3j ) and hyperplastic epithelium of mutant mice (Figure 3k ).
Inactivation of stromal BMPRII increases the myofibroblastic population in the colonic mucosa Actin and vimentin immunoreactivity in the colonic mucosa was used to distinguish intestinal myofibroblasts, which are actin-and vimentin-positive, from lamina propria fibroblasts, which are actin-negative and vimentin-positive (Adegboyega et al., 2002) . In the normal colon, a-smooth muscle actin immunostaining was detected in the pericryptal region, comprising the lower half of the mucosa (Figure 5a ), while vimentin stained both pericryptal and nonpericryptal regions throughout the mucosa (Figure 5c ). In polyps from mutant mice, actin-immunoreactivity was prominent throughout the lamina propria, consistent with expansion of the myofibroblast cell population (Figure 5b) . Actin staining showed similar expansion throughout the Figure 2 Conditional inactivation of BMPRII in the colorectum leads to intestinal bleeding. BMPRII/nestin-Cre mice were generated as shown (a). Bloody stool filled the colon of mutant mice (b, arrow), while no blood was present in the small intestine (b, arrowhead). Mutant mice had enlargement of the spleen (c, upper spleen) compared to control littermates (c, lower spleen). The wall of the colorectum was also markedly thickened in mutants (e) compared to controls (d). Multiple polypoid masses were observed in mutant colon (e, arrows).
Stromal deletion of BMPRII causes colonic polyps H Beppu et al mutant colonic mucosa, even in non-polyp regions (data not shown). As in normal colon, vimentin staining was evident in the pericryptal and nonpericryptal regions of the polyp, although the stromal staining was more prominent (Figure 5d ).
Activation of b-catenin occurs in polyps
Activation of Wnt signaling is an initiating event in the formation of adenomatous polyps (He et al., 2004) . A hallmark of Wnt activation is nuclear accumulation of b-catenin, which promotes cell proliferation. b-Catenin expression was strongest along the borders of epithelial cells in control colon, with strongest expression toward the mucosal surface (Figure 5e ). The polyps, however, demonstrated uniform b-catenin staining throughout the epithelium. Moreover, patchy nuclear localization of b-catenin was observed (Figure 5f , arrows).
Discussion
BMP signaling maintains homeostasis in the intestinal epithelium by promoting epithelial cell apoptosis , g and j) , non-polypoid areas of mutant colons (b, e, h and k), and polyps (c, f, i and l). Marked epithelial expansion was observed throughout the colorectum of mutants (b) with increased goblet cells and mucin production shown by alcian blue staining (e). Polyps displayed dramatic epithelial overgrowth (c) with a significant increase in mucin secretion (f). PCNA expression, normally limited to the base of the crypts (g), was markedly enhanced throughout the colorectal epithelium (h). In polyps, PCNA activity extended to the luminal surface (i) and was present in both epithelial and mesenchymal cells (i, arrow). Apoptotic cells were detected by TUNEL assay in control (j, arrows) and non-polypoid area of mutant colons (k, arrows) but were markedly diminished in polyps (l). (Hardwick et al., 2004) and inhibiting stem cell renewal (He et al., 2004) . This activity is counterbalanced by Wnt signaling, which acts through b-catenin to stimulate proliferation of intestinal stem cells (Sancho et al., 2003; He et al., 2007) . Consequently, inhibition of BMP signaling leads to dysregulation of the balance between epithelial proliferation and apoptosis and the subsequent initiation of polyposis in the small intestine (Haramis et al., 2004; He et al., 2004) and colon (Batts et al., 2006; Liu et al., 2007) . Polyp formation in existing mouse models of juvenile polyposis results from targeted inactivation of BMP activity in epithelial cells, either via inactivation of BMPRIA (He et al., 2004) or by transgenic expression of noggin (Haramis et al., 2004) . These results suggest that the epithelium is primarily responsible for tumorigenesis in the intestine. The role of the stroma in initiating polyp formation is unknown. However, loss of a tumor suppressor locus at 10q22 has been identified in the lamina propria, and not epithelium, in some cases of juvenile polyps in humans (Jacoby et al., 1997) , suggesting that genetic mutations in the stroma may also contribute to tumorigenesis. Moreover, hamartomatous polyps and carcinomas of the colon display histologic abnormalities in both epithelial and stromal elements (Jacoby et al., 1997; Powell et al., 2005) suggesting that stromal-epithelial interactions may underlie the development and maintenance of these lesions.
Inactivation of BMPRII in the stromal cells of the colonic mucosa leads to overgrowth of the epithelium Figure 4 Hamartomatous polyps develop in the mutant colorectum. Sessile polypoid lesions were present on the mucosal surface of the colorectum of mutant mice (a, arrow). Cross-sections of these polyps revealed epithelial hyperplasia with elongation and cystic dilation of the crypts (b and c). Cre-mediated recombination was not observed in the epithelium of the polyp following whole-mount staining for b-galactosidase activity (d). Histochemistry for b-galactosidase activity (e) and immunoreactivity (f) revealed Cre activity in the lamina propria but not in the epithelium.
Stromal deletion of BMPRII causes colonic polyps H Beppu et al
and the development of hamartomatous polyps. Interestingly, epithelial hyperplasia was observed along the entire length of the colorectum, yet polyp formation was limited to a small portion of the epithelial surface, suggesting that the stromal BMPRII mutation alone may not be sufficient to initiate polyposis, but that a second mutation event may be required. The rapid epithelial proliferation induced by the loss of BMPRII signaling in stromal tissue may predispose those epithelial cells to secondary genetic events. Interestingly, while stromal expression of Cre recombinase was observed in the small intestine, no polyps were seen proximal to the cecum, suggesting regional differences in the role of stromal BMP signaling. While intestinal polyps can cause mucosal bleeding, we found no evidence that the blood observed in the mutant colon came from the surface of the polyps. Recently, BMPRIIknockdown mice generated using short hairpin RNA were found to have intestinal mucosal bleeding due to altered vessel integrity (Liu et al., 2007) . This observation Figure 5 Stromal inactivation of BMPRII increases the myofibroblast population in the colonic mucosa. Sections of normal colon (a and c) and of polyps from mutant mice (b and d) were stained with antibodies against a-smooth muscle actin (a and b) and vimentin (c and d), demonstrating a marked increase in myofibroblastic cells throughout the lamina propria of the polyp. b-Catenin was strongly expressed along epithelial cell borders near the luminal surface in control colon (e), while mutant polyps displayed uniform expansion of b-catenin staining with patchy nuclear localization (f, arrows). may account for the colorectal bleeding observed in BMPRII/nestin-Cre mutant mice.
The development of polyps in BMPRII/nestin-Cre intestine was associated with increased nuclear localization of b-catenin in colonic epithelial cells. Wnt activation, via nuclear b-catenin, normally drives stem cell proliferation in the intestinal epithelium, with excessive Wnt activation leading to intestinal polyposis and colorectal cancer (Sancho et al., 2003; He et al., 2004) . BMP signaling normally suppresses Wnt activity by activating phosphate and tensin homolog (PTEN), a negative cell-cycle regulator that inhibits phosphatidylinositol-3 kinase (PI3K)-Akt activity (He et al., 2004) . Akt promotes nuclear localization of b-catenin. Hence, loss of BMP signaling releases the inhibition of PTEN, allowing activation of PI3k/Akt, nuclear localization of b-catenin, and an increase in intestinal stem cell number resulting in excessive epithelial proliferation. We have shown that stromal inactivation of BMPRII produces epithelial cell proliferation associated with nuclear localization of b-catenin. These observations suggest that mutations in the BMP signaling pathway in either the epithelium or its stromal environment may initiate a similar cascade of events leading to polyp formation.
Our results support a central role for stromal cells in the genesis of epithelial tumors, as has been described by others. Inactivation of the TGF-b type II receptor in stromal fibroblasts leads to intraepithelial neoplasia in the prostate and squamous cell carcinoma of the stomach in mice (Bhowmick et al., 2004a) . Similarly, mammary fibroblasts engineered to overexpress either HGF or TGF-b induce malignant epithelial neoplasms of the breast (Kuperwasser et al., 2004) . These studies point to the influence of the tumor environment, and of fibroblasts in particular, in the initiation of neoplasia. We noted a dramatic expansion of the myofibroblastic cell population in the BMPRII-deficient stroma. Myofibroblasts, which mediate the flow of information between the epithelium and stroma of the intestinal mucosa via the elaboration of cytokines, growth factors and other molecules (Powell et al., 2005) , are normally limited to the pericryptal compartment. However, the polyps seen in BMPRII/nestin-Cre mice exhibited a marked increase in the number of a-smooth muscle actin-positive myofibroblasts throughout the lamina propria, as has been described in hyperplastic and adenomatous polyps of the colorectum (Adegboyega et al., 2002) . The increased number of myofibroblasts may have a direct role in the development of epithelial hyperplasia, as myofibroblasts have been shown to promote the proliferation of colon cancer cells in culture (Chen et al., 2005) . Stromal fibroblasts thus appear to have an important role in epithelial tumor initiation. Carcinoma is believed to arise from transformed epithelial cells that enlist adjacent mesenchymal cells to support their survival, proliferation and invasiveness (Hanahan and Weinberg, 2000) . However, we show that genetic mutations in the intestinal stroma can induce epithelial neoplasia in the colon, suggesting that genetic mutations in either the epithelial or stromal compartments can initiate the events leading to polyp formation and cancer.
On the basis of our results, we propose a model for the role of stromal BMP signaling in the colon (Figure 6 ). Similar to its role in the epithelium, BMP signaling in the lamina propria has a suppressive effect on epithelial proliferation. Inactivation of stromal BMPRII releases this growth inhibitory effect and leads to epithelial hyperplasia. Several mechanisms may account for this effect. Loss of BMPRII signaling may promote the secretion of growth factors that act on epithelial cells or decrease the elaboration of growth inhibitory factors, thus leading to epithelial overgrowth. Possible candidate growth factors include HGF and TGF-b1, both of which are stromally derived promoters of epithelial malignancies (Bhowmick et al., 2004a, b) . Alternatively, stromal BMPRII deletion may act indirectly, by increasing myofibroblast proliferation, which in turn can promote epithelial cell proliferation (Chen et al., 2005) . The stromal microenvironment therefore not only plays a critical role in the maintenance and progression of tumor growth but also appears to have a central role in its initiation. Clarifying the cellular and molecular bases of these stromal-epithelial interactions will improve our understanding of the development of colonic polyps and their progression to cancer.
Materials and methods
Mice
Mice carrying a BMPRII allele in which exons 4 and 5 were flanked by loxP sequences were generated previously (Beppu et al., 2005) . Nestin-Cre transgenic mice were obtained from Gail Martin (Trumpp et al., 1999) . The ROSA26 reporter (R26R) mice were purchased from Jackson Labs (Bar Harbor, ME, USA). All control and mutant mice used in this study carried the R26R transgene. Experiments using animals were approved by the Massachusetts General Hospital Subcommittee on Research Animal Care.
Histology
Intestines were fixed in 4% paraformaldehyde (PFA) in phosphate-buffered saline (PBS) at 41C overnight, embedded in paraffin, and sectioned at 8 mm thickness. Sections were stained with hematoxylin and eosin. To identify intestinal cells expressing b-galactosidase, sections and whole-mount tissues were incubated with 5-bromo-4-chloro-3-indolyl b-D-galactopyranoside (X-gal) as described previously (Hogan et al., 1994) . For alcian blue staining, sections were de-paraffinized and hydrated with distilled water, followed by incubation with 1% alcian blue in 3% acetic acid for 30 min. Nuclear fast red (Vector Labs, Burlingame, CA, USA) was used for counterstaining the X-gal-and alcian blue-stained sections.
Immunohistochemistry
Intestinal tissue sections were reacted with primary antibodies, including proliferating cell nuclear antigen (PCNA, NeoMarkers, Fremont, CA, USA), a-smooth muscle actin (Santa Cruz Biotech, Santa Cruz, CA, USA), vimentin (Santa Cruz Biotech), and b-catenin (Zymed Laboratories, San Francisco, CA, USA). Bound primary antibodies were detected using appropriate secondary antibodies, the ABC/HRP kit (DakoCytomation, Carpinteria, CA, USA), and diaminobenzidine (Sigma-Aldrich, St Louis, MO, USA). Staining with antib-galactosidase antibody (Molecular Probes, Carlsbad, CA, USA) was performed on 12 mm-thick cryosections cut from formaldehyde-fixed, gelatin-embedded tissue.
TUNEL assay
Apoptotic cells were detected using the TUNEL assay according to the manufacturer's protocol (Promega, Madison, WI, USA). Counterstaining was performed with DAPI mounting media (Vector Labs).
